Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 22:01 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Spironolactone Versus Prednisolone in DMD
NCT03777319 · Kevin Flanigan · PHASE1 · terminated · last registry update 2023-10-23 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Inability to recruit participants.” | – | Registry record, Kevin Flanigan |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against NR3C2 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2024-09-25Also stopped (terminated): Iain Bressendorff, ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib (NCT05897372)
- 2024-09-19Also stopped (withdrawn): Medical University of South Carolina, Spironolactone 50 MG + Spironolactone 100mg (NCT04100083)
- 2024-09-04Also stopped (withdrawn): Medical University of South Carolina, Spironolactone 50Mg Tablet + Spironolactone 100Mg Tablet (NCT03953209)
- 2024-08-30Phase 3 first posted: Zhejiang University, Finerenone + Placebo (NCT06580288)
- 2024-06-24Also stopped (terminated): Assistance Publique Hopitaux De Marseille, Losartan 50 mg and Spironolactone 25 mg pillules oral use (NCT04643691)
- 2024-05-31Also stopped (terminated): Henry Ford Health System, Cilostazol 100 MG (NCT04148105)
- 2024-05-14Phase 3 first posted: Ospedale San Raffaele, Torasemide + Spironolactone (NCT06413082)
- 2024-04-19Results posted on the registry: University of California, San Diego, Progestin Only Contraceptive Pills (NCT04965116)
- 2024-02-06Phase 3 first posted: University of Erlangen-Nürnberg Medical School, Finerenone 20 MG Oral Tablet + Placebo (NCT06244758)
- 2024-01-12Phase 3 first posted: University Hospital, Caen, Spironolactone (NCT06204640)
- 2023-11-18Phase 3 first posted: Merck Sharp & Dohme LLC, Opevesostat + Abiraterone acetate (NCT06136624)
- 2023-11-18Phase 3 first posted: Merck Sharp & Dohme LLC, Opevesostat + Dexamethasone (NCT06136650)
- 2023-11-18Also stopped (suspended): Rennes University Hospital, Fludrocortisone + Placebo (NCT05001854)
- 2023-10-13Phase 3 first posted: Steno Diabetes Center Copenhagen, Aspirin tablet + Semaglutide (NCT06082063)
- 2023-09-28Phase 3 first posted: The George Institute, Finerenone + Placebo Finerenone (NCT06058585)
- 2023-09-13Phase 3 first posted: Colorado Prevention Center, Finerenone + Placebo (NCT06033950)
- 2023-09-06Phase 3 first posted: Colorado Prevention Center, Finerenone + Empagliflozin (NCT06024746)
- 2023-08-23Phase 3 first posted: Colorado Prevention Center, Finerenone + Placebo (NCT06008197)
- 2023-08-16Phase 3 first posted: Grace Therapeutics Inc., GTX-104 + Nimotop 30 MG Oral Capsule (NCT05995405)
- 2023-08-01Results posted on the registry: University Hospitals Cleveland Medical Center, Spironolactone + Placebo (NCT02169089)
- 2023-06-13Phase 3 first posted: Bayer, Finerenone (NCT05901831)
- 2023-06-02Results posted on the registry: Massachusetts General Hospital, Eplerenone + Placebo (NCT02740179)
- 2023-05-24Also stopped (withdrawn): Mayo Clinic, Carvedilol + Lisinopril (NCT04190433)
- 2023-05-09Phase 3 first posted: October 6 University, Dapagliflozin Farxiga® + Ramipril Tritace®, Carvedilol Carvid®,and Spironolactone Aldactone® (NCT05849766)
- 2023-05-03Results posted on the registry: Brigham and Women's Hospital, eplerenone + amiloride (NCT02525796)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision